Pyrazinobenzodiazepines as potent nonpeptide vasopressin receptor antagonists (vol 2, pg 219, 2005)

被引：0
|
作者：
Matthews, JM
机构：
来源：
LETTERS IN DRUG DESIGN & DISCOVERY | 2006年 / 3卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [41] NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS .7. DESIGN AND SYNTHESIS OF A POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST
    DUGGAN, ME
    NAYLOROLSEN, AM
    PERKINS, JJ
    ANDERSON, PS
    CHANG, CTC
    COOK, JJ
    GOULD, RJ
    IHLE, NC
    HARTMAN, GD
    LYNCH, JJ
    LYNCH, RJ
    MANNO, PD
    SCHAFFER, LW
    SMITH, RL
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) : 3332 - 3341
  • [42] A NEW SERIES OF IMIDAZOLONES - HIGHLY SPECIFIC AND POTENT NONPEPTIDE AT(1) ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    BERNHART, CA
    PERREAUT, PM
    FERRARI, BP
    MUNEAUX, YA
    ASSENS, JLA
    CLEMENT, J
    HAUDRICOURT, F
    MUNEAUX, CF
    TAILLADES, JE
    VIGNAL, MA
    GOUGAT, J
    GUIRAUDOU, PR
    LACOUR, CA
    ROCCON, A
    CAZAUBON, CF
    BRELIERE, JC
    LEFUR, G
    NISATO, D
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (22) : 3371 - 3380
  • [43] Nonpeptide bradykinin B2 receptor antagonists:: Conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists
    Dziadulewicz, EK
    Ritchie, TJ
    Hallett, A
    Snell, CR
    Davies, JW
    Wrigglesworth, R
    Dunstan, AR
    Bloomfield, GC
    Drake, GS
    McIntyre, P
    Brown, MC
    Burgess, GM
    Lee, W
    Davis, C
    Yaqoob, M
    Phagoo, SB
    Phillips, E
    Perkins, MN
    Campbell, EA
    Davis, AJ
    Rang, HP
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (11) : 2160 - 2172
  • [44] GnRH antagonists in IVF (vol 10, pg 705, 2005)
    Kolibianakis, EM
    Tarlatzis, B
    Devroey, P
    REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 11 (02) : 271 - 271
  • [45] STRUCTURE-SELECTIVITY RELATIONSHIP OF HIGHLY POTENT AND SELECTIVE NONPEPTIDE DELTA-OPIOID RECEPTOR ANTAGONISTS
    SULTANA, M
    PORTOGHESE, PS
    TAKEMORI, AE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 13 - MEDI
  • [46] Novel, potent, selective and brain penetrant vasopressin 1b receptor antagonists
    Geneste, Herve
    Bhowmik, Swati
    van Gaalen, Marcel M.
    Hornberger, Wilfried
    Hutchins, Charles W.
    Netz, Astrid
    Oost, Thorsten
    Unger, Liliane
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (19) : 3260 - 3264
  • [47] Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease
    Cao, Xudong
    Wang, Peng
    Yuan, Haoxing
    Zhang, Haoran
    He, Yan
    Fu, Kequan
    Fang, Qian
    Liu, Hongli
    Su, Limin
    Yin, Long
    Xu, Pei
    Xie, Yuyang
    Xiong, Xiaochun
    Wang, Junqi
    Zhu, Xu
    Guo, Dong
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9295 - 9311
  • [48] Solution NMR spectroscopy of the human vasopressin V2 receptor, A G protein-coupled receptor (vol 127, pg 8010, 2005)
    Tian, CL
    Breyer, RM
    Kim, HJ
    Karra, MD
    Friedman, DB
    Karpay, A
    Sanders, CR
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (15) : 5300 - 5300
  • [49] Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia
    Miyazaki, T
    Yamamura, Y
    Onogawa, T
    Nakamura, S
    Kinoshita, S
    Nakayama, S
    Fujiki, H
    Mori, T
    ENDOCRINOLOGY, 2005, 146 (07) : 3037 - 3043
  • [50] Nonpeptide vasopressin receptor antagonists:: development of selective and orally active V1a, V2 and V1b receptor ligands
    Serradeil-Le Gal, C
    Wagnon, J
    Valette, G
    Garcia, G
    Pascal, M
    Maffrand, JP
    Le Fur, G
    VASOPRESSIN AND OXYTOCIN: FROM GENES TO CLINICAL APPLICATIONS, 2002, 139 : 197 - 210
12345